The sixth Chinese Conference on Particle Radiation Therapy (CCPRT 2026) ran from 16 to 18 October 2026 with a detail in its programme that overseas patients will find more useful than another machine-opening announcement: HKSH Medical Group, the Hong Kong group that operates the city's proton therapy centre, was invited to serve as one of the hosting organisations, the first time a Hong Kong medical group has taken that role in this conference series. On 17 October, during the conference, the Hong Kong Sanatorium & Hospital Cancer Centre held the certificate ceremony for its 2025–2026 proton therapy training programme, graduating a first cohort of 40 participants drawn from 11 mainland medical institutions (21st Century Business Herald). The wider event was associated with the Proton and Heavy Ion Radiation Therapy Committee of the China Health Science and Technology Promotion Association and with the Shanghai Proton and Heavy Ion Center. Read together with HKSH's stated intention to present research on cutting a course to two treatment sessions at an international conference next year, this tells an international patient three things: where proton expertise is being built, how mainland and Hong Kong centres now connect, and why the number of sessions — not the number of gantries — is the variable that governs your trip.
Why a training network matters more than another proton machine
Proton therapy is a people-limited service before it is a hardware-limited one. A gantry is a starting point; the scarce resources are radiation oncologists who can select appropriate indications, medical physicists who can build and verify a proton plan, dosimetrists, and therapists comfortable with image guidance and range verification. That is why the CCPRT 2026 certificate ceremony deserves more attention from overseas patients than a facility press release.
The institutions named in the coverage include Peking Union Medical College Hospital in Beijing, the Cancer Hospital of the Chinese Academy of Medical Sciences, Tongji Hospital of Tongji Medical College at Huazhong University of Science and Technology in Wuhan, and the Cancer Center of Renmin Hospital of Wuhan University, whose gastrointestinal tumour department was singled out. Eleven mainland institutions participated in total. On the other side of the ledger, HKSH states that it established the Greater Bay Area's first proton therapy centre in 2023 — currently the only proton centre in Hong Kong — and points to clinical accumulation of more than a thousand proton cases (reported by 21st Century Business Herald).
Three consequences for anyone assessing proton beam therapy in Asia:
- The pool of clinicians competent to judge your indication is wider than the pool of machines. A referral hospital without a proton beamline can still give a technically literate opinion on whether proton therapy is appropriate for you, which matters before you commit to international travel.
- Cross-border referral language is starting to exist. When teams from Beijing, Wuhan and Shanghai train on the same programme, the handover between a treating hospital at home and a proton centre abroad gets easier to document, and it is easier to insist on a shared protocol rather than a translation of expectations.
- Training is not authorisation. None of this states that a named institution accepts self-paying patients from outside China, or quotes international patients at all. Our page on proton therapy in China covers what to verify centre by centre, and the longer proton therapy guide explains how fractionation, indication and site volume interact.
The logistics story: compressing a course into two sessions
HKSH has said it will share research results on reducing the number of treatment sessions to two at an international academic conference next year. That needs stating carefully. A reduced-fraction schedule is a clinical protocol under investigation, not an option currently on any booking form; its appropriateness depends on tumour type, target volume, dose tolerance of nearby organs and the treating team's own protocol. There is no claim here that fewer sessions is better treatment, and no outcome figures should be inferred from a conference announcement.
What is not speculative is the arithmetic of a medical trip. For a cross-border patient, the cost of proton therapy is not only the course fee. It is the nights of accommodation around every treatment day, the accompanying family member, the days of work lost, the airport transfers, and the risk of a schedule slipping while you are hundreds of kilometres from home. Session count is the variable that multiplies across all of those. Shrink the course and the whole trip shrinks with it.
How trip structure changes when beam days fall
| Trip stage | Conventional multi-session course | Compressed course (the direction described by HKSH) |
|---|---|---|
| Pre-treatment workup on arrival | Simulation CT, immobilisation device, plan design and plan approval before the first fraction | Unchanged — these steps still precede the first treatment day |
| Days on site for treatment | Each fraction adds a clinic visit, and total on-site days track the session count | Beam days drop sharply; hotel, transfer and meal costs scale with them |
| Schedule risk | A machine fault, a public holiday or a plan revision can push several remaining sessions | Fewer sessions means less exposure to interruption, but a slip still moves your whole departure date |
| Companion and leave burden | A family member is tied up for weeks rather than days | Materially lighter, and cheaper, for accompanying relatives |
| Follow-up imaging | Review imaging and toxicity checks sit inside the treatment window | Same checks are needed; they can often be shifted to your local hospital if your home team is proton-literate |
| Total cost picture | Course fee plus a long stay | Fewer paid fractions does not guarantee a lower fee, since price per fraction can be set higher — the total course quote is what matters |
The honest reading: a shorter course is a travel and cost lever, not yet a clinical one you can request. Confirm any fractionation plan against the centre's written treatment schedule and quote, because prices, session counts and dates are set by the hospital itself and are only ever reliable "as quoted by the treating centre".
Comparing the Hong Kong centre with the mainland network
The October 2026 reporting supports a limited number of verifiable statements, and leaves the decisive commercial questions unanswered. Separating the two is more useful than a comparison chart built on marketing claims.
| Decision factor | Supported by the CCPRT 2026 reporting | What you must still ask the centre |
|---|---|---|
| Presence of proton capacity | HKSH: centre established 2023, described as the Greater Bay Area's first and Hong Kong's only proton centre; Shanghai Proton and Heavy Ion Center associated with the event | Whether the unit accepts international self-paying patients, and through which office |
| Clinical accumulation | HKSH: more than a thousand proton cases | Case numbers for your specific diagnosis, not for proton therapy overall |
| Trained workforce | First cohort of 40; 11 mainland institutions in the training programme | Which named clinicians would carry your case, and their availability |
| Course length | HKSH intends to present 2-session research at an international conference next year | Whether any reduced-fraction protocol is open now, and its eligibility criteria |
| Cost and waiting time | Not stated | Total course price, deposit, cancellation terms, earliest simulation date |
For the wider picture on choosing between cancer treatment routes in the country, our cancer treatment in China service page and the medical tourism guide set out how patients normally sequence opinions, appointments and travel.
Questions to put to every proton centre before you commit
- Which of my diagnosis-specific proton cases can you show experience with, and who is the named treating physician?
- What is the total course fee as quoted, inclusive of simulation, immobilisation devices, plan approval, all fractions and restaging imaging?
- What is the earliest date I can be on site for simulation, and what is the gap to the first treatment day?
- Which fractionation schedule is planned for me, and if a reduced-fraction protocol is proposed, is it standard practice or a study — and where is it published?
- What happens to my booking if a machine is unavailable mid-course, and who pays for the extra nights?
- Which documents do you need in advance, in which language, and will a treatment plan be issued before I buy a ticket?
- What follow-up can be done in my home country, and what will you send to my local oncologist?
Paperwork that a shorter course does not solve
A compressed schedule changes your hotel budget, not your compliance obligations. If you are travelling to China for treatment, the medical-visa route, insurance notification and record transfer still come first; see the China medical visa guide for the documentation logic. Imaging should arrive as original DICOM data rather than screenshots, pathology blocks or slides may need to be shipped rather than described, and a written summary from your current oncologist should state prior doses if you have had radiotherapy before.
On the mainland side, the practical bottleneck for overseas patients is usually getting the first specialist appointment rather than finding a beamline. If your route goes through Shanghai — including the institutions connected to this conference — the mechanics of booking an international-patient appointment are covered on our Shanghai hospital appointment page. Nothing in this article is medical advice: whether proton therapy suits you, and how many sessions it should take, can only be decided by a licensed physician who has reviewed your records and examined you in person.
Bottom line
The most durable finding from CCPRT 2026 is structural. A Hong Kong proton centre is now training clinicians across 11 mainland institutions, and a conference series that historically looked inward has given that group a hosting role. For international patients, that means a denser layer of proton-literate clinicians in Asia, a clearer distinction between Hong Kong's single established private centre and the mainland network, and a genuine possibility that treatment-course length will come down enough to change what a trip costs. Verify all of it centre by centre before you fly.
Get a case-by-case read before you book
OriEast can help you assemble and translate your medical records, approach the proton centres that fit your diagnosis, obtain written quotations and total-course pricing, arrange appointments and on-site coordination, and keep a bilingual thread open with the treating team through your stay — including what gets sent back to your oncologist at home. Start a case evaluation so we can assess which centres are realistically open to your situation, or send a general inquiry about timelines, documents and coordination support.